Global smart biopsy devices market size to growing at 5.7% CAGR through 2027

According to the research report titled ‘Global Smart Biopsy Devices Market Size study, by Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Others) and Regional Forecasts 2020-2027’, available with Market Study Report LLC, global smart biopsy devices market had reached a valuation of USD 2.5 billion in the year 2019 and  is likely to showcase a y-o-y growth rate of 5.7% between 2020 and 2027.

Rising adoption of biopsies for cancer diagnosis is one of the key factors driving the growth of global smart biopsy devices market. For those uninitiated, a biopsy is a medical test that is usually employed while screening and identifying cancer among patients. Technological advancements in biopsies has resulted in development of non-invasive techniques, which in turn is stimulating the overall industry outlook.

These non-invasive biopsy tools allow for real-time cancer identification, and hence widely being adopted in hospitals in order to accelerate the disease diagnosis. Moreover, these devices help interventional radiologists or the diagnostic department while separating the healthy cells from the tumor.

Citing an instance, the IARC (International Agency for Research on Cancer) states that around 17 million new cancer cases were recorded in 2018, with mortality numbers reaching 9.5 million. The agency further claimed that the number of new cancer cases is expected to account for 27.5 million in the year 2040. Thus, increased pervasiveness of cancer has augmented the demand for smart biopsy devices, thereby amplifying the overall market size.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2854748/

Apart from this, increasing utilization of smart biopsy devices amidst the ongoing COVID-19 pandemic in order to offer better patient care and to avoid the spread of the disease is facilitating the business scenario. However, clinical issues associated with core needle biopsy may act as a restraining factor to the growth of global smart biopsy devices industry.

Considering the geographical landscape, North America currently dominates global smart biopsy devices market in terms revenue share and is predicted to showcase similar expansion patterns in the ensuing years. The growth is attributable to availability of early diagnostic techniques as well as advanced healthcare infrastructure and increasing awareness pertaining to cancer screening programs.

Meanwhile, Asia-Pacific smart biopsy devices industry size is expected to grow significantly during the study duration, owing to rising prevalence of breast and skin cancer and improving healthcare infrastructure.

The competitive landscape of global smart biopsy devices market sphere is defined by companies such as Cytogen Corporation, Becton, Dickinson and Company, Dune Medical Devices Ltd., Interventional Systems, Boston Scientific Corporation, Canon Medical Systems Corp., Intuitive Surgical Inc., InnoMedicus AG, and Danaher Corporation among others.

To access a sample pages of this report titled “Global Smart Biopsy Devices Market Size study, by Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Others) and Regional Forecasts 2020-2027” in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/global-smart-biopsy-devices-market-size-research

Related Report:

Global Needle Biopsy Market Size, and Regional Forecasts 2020-2027

Global Needle Biopsy Market is valued approximately USD 552.80 million in 2019 and is anticipated to grow with a healthy growth rate of more than 5.20 % over the forecast period 2020-2027. Needle biopsy is a process which is used to collect the sampled of cells from the body. The fine needle biopsy and core needle biopsy are two types of common needle biopsy. They are usually used to take samples from the muscle, bones and other part of the body. Also, the needle biopsy is usually done to detect certain symptoms such as infection, inflammation and mass or lump. In addition, this is considered as a key approach to rule out or diagnose breast cancer.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

 
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com

News: http://business-newsupdate.com/

Back to news